1 results match your criteria: "Sheba Medical Center (Rosner[Affiliation]"
Effect of Rho-associated kinase inhibitor on human corneal endothelial cell apoptosis.
J Cataract Refract Surg
April 2020
From the Department of Ophthalmology, Edith Wolfson Medical Center (Achiron, Karmona, Pe'er, Avizemer, Bartov, Burgansky), Holon, Sackler Faculty of Medicine, Tel Aviv University (Achiron, Feldman, Karmona, Pe'er, Avizemer, Bartov, Burgansky, Rosner, Vishnevskia-Dai), Tel Aviv, The Multiple Sclerosis Center, Sheba Medical Center (Feldman), and The Goldschleger Eye Institute, Sheba Medical Center (Rosner, Vishnevskia-Dai), Tel Hashomer, Israel.
Purpose: To evaluate whether exposure to Rho-associated protein kinase (ROCK) inhibitor will promote human-cultured corneal endothelial cells (CECs) survival in a commercial storage medium.
Setting: Edith Wolfson Medical Center, Holon, and Sheba Medical Center, Tel Hashomer, Israel.
Design: Experimental study.